Maximus (NYSE:MMS) Issues FY 2025 Earnings Guidance

Key Points

• Maximus has updated its FY 2025 earnings guidance to an expected earnings per share of 7.350-7.550, higher than the consensus estimate of 6.500, and revenue guidance of $5.4 billion-$5.5 billion, matching the consensus.
• The company recently announced a quarterly dividend of $0.30 per share, which translates to an annual yield of 1.6%, with a dividend payout ratio of 23.86%.
• In market activity, Maximus stock opened at $74.81, has a market cap of $4.22 billion, and institutional investors own approximately 97.21% of the shares.

Maximus (NYSE:MMS - Get Free Report) updated its FY 2025 earnings guidance on Thursday. The company provided earnings per share guidance of 7.350-7.550 for the period, compared to the consensus earnings per share estimate of 6.500. The company issued revenue guidance of $5.4 billion-$5.5 billion, compared to the consensus revenue estimate of $5.4 billion.

Wall Street Analysts Forecast Growth

Separately, Wall Street Zen downgraded Maximus from a "buy" rating to a "hold" rating in a report on Thursday, May 15th.

Maximus Price Performance

Shares of Maximus stock opened at $74.81 on Thursday. The stock has a market cap of $4.22 billion, a P/E ratio of 14.87 and a beta of 0.60. The company has a debt-to-equity ratio of 0.87, a quick ratio of 1.84 and a current ratio of 1.84. The stock's fifty day moving average is $71.43 and its 200 day moving average is $70.49. Maximus has a one year low of $63.77 and a one year high of $93.94.

Maximus (NYSE:MMS - Get Free Report) last posted its quarterly earnings results on Thursday, August 7th. The health services provider reported $2.16 earnings per share for the quarter, topping analysts' consensus estimates of $1.39 by $0.77. Maximus had a net margin of 5.56% and a return on equity of 23.37%. Sell-side analysts anticipate that Maximus will post 6.15 earnings per share for the current year.

Maximus Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Sunday, August 31st. Investors of record on Friday, August 15th will be paid a dividend of $0.30 per share. This represents a $1.20 annualized dividend and a yield of 1.6%. The ex-dividend date of this dividend is Friday, August 15th. Maximus's dividend payout ratio (DPR) is 23.86%.

Insider Buying and Selling

In other Maximus news, Director Gayathri Rajan sold 7,913 shares of the stock in a transaction that occurred on Friday, May 30th. The shares were sold at an average price of $72.38, for a total transaction of $572,742.94. Following the completion of the sale, the director directly owned 14,205 shares of the company's stock, valued at $1,028,157.90. This trade represents a 35.78% decrease in their position. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Corporate insiders own 1.60% of the company's stock.

Hedge Funds Weigh In On Maximus

Several institutional investors have recently bought and sold shares of the stock. Jane Street Group LLC grew its position in shares of Maximus by 941.2% during the first quarter. Jane Street Group LLC now owns 98,273 shares of the health services provider's stock valued at $6,701,000 after purchasing an additional 88,835 shares in the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC grew its holdings in Maximus by 7.0% during the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 180,690 shares of the health services provider's stock valued at $12,321,000 after buying an additional 11,754 shares in the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its stake in Maximus by 0.6% in the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 34,476 shares of the health services provider's stock worth $2,351,000 after acquiring an additional 221 shares during the last quarter. Finally, Royal Bank of Canada raised its holdings in shares of Maximus by 146.2% during the 1st quarter. Royal Bank of Canada now owns 19,732 shares of the health services provider's stock worth $1,345,000 after acquiring an additional 11,716 shares in the last quarter. 97.21% of the stock is owned by hedge funds and other institutional investors.

Maximus Company Profile

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.